UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19 vaccination: The road ahead

Science (American Association for the Advancement of Science), 2022-03, Vol.375 (6585), p.1127-1132

2022

Volltextzugriff (PDF)

What policy makers need to know about COVID-19 protective immunity

The Lancet (British edition), 2020-05, Vol.395 (10236), p.1527-1529

2020

Volltextzugriff (PDF)

Immunity to SARS-CoV-2 variants of concern

Science (American Association for the Advancement of Science), 2021-03, Vol.371 (6534), p.1103-1104

2021

Volltextzugriff (PDF)

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?

Nature reviews. Immunology, 2021-12, Vol.21 (12), p.762-768

2021

Volltextzugriff (PDF)

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

The Lancet (British edition), 2021-03, Vol.397 (10279), p.1057-1058

2021

Volltextzugriff (PDF)

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

npj vaccines, 2021-05, Vol.6 (1), p.74-74, Article 74

2021

Volltextzugriff (PDF)

Narrating the natural history of live infection by SARS CoV-2 VOC in animal models

EBioMedicine, 2021-12, Vol.74, p.103704-103704, Article 103704

Altmann, Daniel M

2021

Volltextzugriff (PDF)

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity

Nature communications, 2023-08, Vol.14 (1), p.5139-5139, Article 5139

2023

Volltextzugriff (PDF)

Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosis

Nature communications, 2024-03, Vol.15 (1), p.2020-2020, Article 2020

2024

Volltextzugriff (PDF)

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy

Journal for immunotherapy of cancer, 2021-09, Vol.9 (9), p.e003311

2021

Volltextzugriff (PDF)

Design, recruitment, and microbiological considerations in human challenge studies

The Lancet infectious diseases, 2015-07, Vol.15 (7), p.840-851

2015

Volltextzugriff (PDF)

A Nobel Prize‐worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens

Immunology, 2018-11, Vol.155 (3), p.283-284

Altmann, Daniel M.

2018

Volltextzugriff (PDF)

Antibiotic therapy and outcome from immune-checkpoint inhibitors

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.287-8, Article 287

2019

Volltextzugriff (PDF)

The COVID-19 immunology masterclass enters its fourth year

Nature immunology, 2023-02, Vol.24 (2), p.201-202

Altmann, Daniel M

2023

Volltextzugriff (PDF)

Children and the return to school: how much should we worry about covid-19 and long covid?

BMJ (Online), 2021-03, p.n701

Altmann, Daniel M

2021

Volltextzugriff (PDF)

The immunology of long COVID

Nature reviews. Immunology, 2023-10, Vol.23 (10), p.618-634

2023

Volltextzugriff (PDF)

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

EBioMedicine, 2022-11, Vol.85, p.104293, Article 104293

2022

Volltextzugriff (PDF)

Long covid: where are we, what does it say about our pandemic response, and where next?

BMJ (Online), 2023-12, Vol.383, p.p2972

2023

Volltextzugriff (PDF)

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection

EBioMedicine, 2021-03, Vol.65, p.103259-103259, Article 103259

2021

Volltextzugriff (PDF)

Consensus on the development of vaccines against naturally acquired melioidosis

Emerging infectious diseases, 2015-06, Vol.21 (6)

2015

Volltextzugriff (PDF)

Hybrid Immunity Results in Enhanced and More Sustained Antibody Responses after the Second Sinovac-CoronaVac Dose in a Brazilian Cohort: DETECTCoV-19 Cohort

Viruses, 2023-09, Vol.15 (10), p.1987

2023

Volltextzugriff (PDF)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition

Cell reports. Medicine, 2021-05, Vol.2 (5), p.100286-100286, Article 100286

2021

Volltextzugriff (PDF)

Risk of SARS-CoV-2 reinfection after natural infection

The Lancet (British edition), 2021-03, Vol.397 (10280), p.1161-1163

2021

Volltextzugriff (PDF)

1 – 25 von 330

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(318)
Mit Volltextzugriff
(303)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(245)
Life Sciences & Biomedicine
(212)
Humans
(198)
Immunology
(103)
Animals
(89)
Female
(70)
Mice
(69)
Male
(68)
Adult
(58)
Middle Aged
(49)
Mice, Transgenic
(42)
Neurosciences & Neurology
(41)
Biological And Medical Sciences
(39)
Covid-19
(35)
T-Lymphocytes - Immunology
(34)
Multiple Sclerosis
(31)
Neurosciences
(29)
Clinical Neurology
(28)
Multidisciplinary Sciences
(28)
Science & Technology - Other Topics
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

COVID-19 vaccination: The road ahead

What policy makers need to know about COVID-19 protective immunity

Immunity to SARS-CoV-2 variants of concern

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

Narrating the natural history of live infection by SARS CoV-2 VOC in animal models

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity

Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosis

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy

Design, recruitment, and microbiological considerations in human challenge studies

A Nobel Prize‐worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens

Antibiotic therapy and outcome from immune-checkpoint inhibitors

The COVID-19 immunology masterclass enters its fourth year

Children and the return to school: how much should we worry about covid-19 and long covid?

Serum biomarkers associated with SARS-CoV-2 severity

The immunology of long COVID

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

Long covid: where are we, what does it say about our pandemic response, and where next?

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection

Consensus on the development of vaccines against naturally acquired melioidosis

Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia

Hybrid Immunity Results in Enhanced and More Sustained Antibody Responses after the Second Sinovac-CoronaVac Dose in a Brazilian Cohort: DETECTCoV-19 Cohort

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition

Risk of SARS-CoV-2 reinfection after natural infection

Suchergebnisse filtern